No Data
No Data
Boill Healthcare Cuts Loss in Fiscal 2024; Shares Drop Over 7%
Boill Healthcare Holdings (HKG:1246) reported a loss from continued operation attributable to owners of HK$118.6 million for the fiscal year ended March 31, compared with HK$233.6 million a year earli
Boillhealthcare (01246.HK) annual net loss attributable to owners of the company was HKD 119 million.
On July 2, GlobeNewswire reported that Boillhealthcare (01246.HK) announced that its revenue for the fiscal year ended March 31, 2024 was HKD 285 million, a decrease of 18.11% year-on-year. The loss attributable to shareholders of the company for the period was HKD 119 million, compared with a loss of HKD 428 million in the same period last year. The basic loss per share was 8.74 Hong Kong cents. The main reason for the revenue decrease was that there were no sales of building materials in the 2024 fiscal year, while the sales of building materials were about HKD 17.86 million. However, the property delivered by the Yangzhong project increased from approximately HKD 169.5 million in the 2023 fiscal year to HKD 285.0 million in the 2024 fiscal year.
BOILLHEALTHCARE: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2024
Express News | Boill Healthcare - Trading in Shares Halted Wef 9 Am on 2 July Pending Announcement on Annual Results
Boillhealthcare (01246) will be suspended from July 2nd, and the reason is pending announcement.
Boillhealthcare (01246) announced that its shares will be temporarily suspended from trading at 9:00 am on July 2, 2024.
Boillhealthcare (01246.HK) was briefly suspended this morning.
On July 2nd, Gelonhui announced that trading of boillhealthcare (01246.HK) shares will be suspended starting at 9:00 am today (07/02/2024).
No Data
黄仁勋 : I pm you, can you see?